Quotes 5-day view Delayed Nasdaq
05/18/2022
05/19/2022
05/20/2022
05/23/2022
05/24/2022
Date
1.6(c)
1.7(c)
1.74(c)
1.73(c)
1.6(c)
Last
20 275
11 720
15 086
10 890
24 352
Volume
+3.90%
+6.25%
+2.35%
-0.57%
-7.51%
Change
Estimated financial data (e) (USD)
Sales 2022
-
-
-
Net income 2022
-77,3 M
-
-
Net Debt 2022
23,3 M
-
-
P/E ratio 2022
-1,01x
Yield 2022
-
Sales 2023
-
-
-
Net income 2023
-89,7 M
-
-
Net Debt 2023
123 M
-
-
P/E ratio 2023
-1,18x
Yield 2023
-
Capitalization
84,1 M
84,1 M
-
EV / Sales 2022
-
EV / Sales 2023
-
Nbr of Employees
59
Free-Float
76,3%
Axcella Health Inc. is a clinical-stage biotechnology company focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). The Company’s product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with the goal of simultaneously impacting multiple biological pathways. AXA1665 is being developed as a product candidate...
Ratings of Axcella Health Inc.
All news about AXCELLA HEALTH INC.
News in other languages on AXCELLA HEALTH INC.
Analyst Recommendations on AXCELLA HEALTH INC.
History shows stocks can weather rate hike cycle
Chart AXCELLA HEALTH INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends AXCELLA HEALTH INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,60 $
Average target price
11,50 $
Spread / Average Target
619%
Please enable JavaScript in your browser's settings to use dynamic charts.